Mordor Intelligence has published a new report on the prostate cancer market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Investigators compared cancer-specific survival rates after synchronous vs metachronous metastasis in patients with surgically treated renal cell carcinoma (RCC).

After her own health decline led to a second kidney transplant, a San Diego healthcare worker returns to work thanks to a ...

So, I walked out of there with a heart monitor that I wore for three weeks. It showed that my heart rate got up to 180 while ...

It's life-changing in more ways than one.

Newport Beach-based Hoag Hospital plans to launch an organ transplant center starting with a liver and kidney transplant ...

Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily ...

Living donors are highly sought because their organs have a higher rate of success than those taken from a dead person. What ...

Researchers developed a computational “virtual twin” that uses patient-specific clinical data to predict how the cancer drug ...

A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in ...